Hormone Therapy

The effects of feminization hormone therapy on the brain of transgender women: A hypothesis.

TL;DR

The authors hypothesize that estradiol in gender-affirming hormone therapy acts on astrocytes to alter cerebral blood flow, water metabolism, and metabolite concentration, potentially explaining the higher risk of stroke observed in GAHT-treated transgender women compared to untreated cisgender men.

Key Findings

GAHT in transgender women leads to a reduction in brain tissue with an expansion of the ventricles.

  • This finding is cited as an established result from prior research on gender-affirming hormone therapy (GAHT).
  • The reduction in brain tissue is accompanied by ventricular expansion, suggesting volumetric changes in the brain.
  • The paper presents this as background context for their hypothesis about the mechanisms involved.

An animal model studying the effects of GAHT suggests dehydration of brain tissue and an alteration in the relative concentration of brain metabolites.

  • The animal model is discussed as evidence supporting the mechanistic hypothesis.
  • Both dehydration of brain tissue and altered metabolite concentrations are identified as effects observed in the model.
  • This animal model data is used to inform the hypothesis about estradiol's effects on the brain.

The authors hypothesize that estradiol acts on astrocytes to alter cerebral blood flow, water metabolism, and metabolite concentration.

  • Estradiol is identified as the key hormonal agent in GAHT responsible for the hypothesized brain changes.
  • Astrocytes are proposed as the cellular mediators through which estradiol exerts its effects.
  • Three specific physiological processes are implicated: cerebral blood flow, water metabolism, and metabolite concentration.
  • This hypothesis is presented as a mechanistic explanation for the observed brain tissue changes in GAHT-treated transgender women.

GAHT-treated transgender women have a higher risk of stroke compared to untreated cisgender men.

  • The elevated stroke risk in GAHT-treated transgender women is presented as an observed clinical phenomenon.
  • The authors argue that the hypothesized changes in cerebral blood flow, water metabolism, and metabolite concentration could explain this elevated stroke risk.
  • The comparison group is specifically described as 'untreated cisgender men.'
  • No specific risk ratios or epidemiological statistics are provided in the abstract.

Future studies should clarify the mechanisms underlying brain tissue changes induced by GAHT.

  • The authors call for future research to investigate the mechanistic basis of GAHT-induced brain changes.
  • This recommendation follows from the hypothesis presented, indicating current mechanistic understanding remains incomplete.
  • The paper frames itself as a hypothesis paper rather than an empirical study reporting new data.

Have a question about this study?

Citation

Zubiaurre-Elorza L, Uribe C, Marcos A, Fernández R, Pásaro E, Del Cerro M, et al.. (2025). The effects of feminization hormone therapy on the brain of transgender women: A hypothesis.. Journal of neuroendocrinology. https://doi.org/10.1111/jne.70026